SANIA TX LTD

13756774
Active London

Research and experimental development on biotechnology

13 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
S

SANIA TX LTD

13756774

Research and experimental development on biotechnology

Founded 22 Nov 2021 Active London, England 13 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

SANIA RX LTD 22 Nov 2021 — 29 Apr 2025
Accounts Submitted 15 Jan 2026 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 4 Dec 2025 Next due 5 Dec 2026 5 months remaining
Net assets £730K £306K 2024 year on year
Total assets £1M £587K 2024 year on year
Total Liabilities £400K £281K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Waterfront Building Manbre Wharf Manbre Road London W6 9RH England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SANIA TX LTD (13756774), an active life sciences and medical technology company based in London, England. Incorporated 22 Nov 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type total-exemption-full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£42.03k

Decreased by £74.98k (-64%)

Net Assets

£730.47k

Increased by £306.47k (+72%)

Total Liabilities

£400.05k

Increased by £280.93k (+236%)

Turnover

N/A

Employees

13

Increased by 3 (+30%)

Debt Ratio

35%

Increased by 13 (+59%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1May 2024Seed
Investor 2May 2024Seed
Investor 3May 2024Seed

Officers

Officers

1 active 2 resigned
Status
Robert Morris BrownstoneDirectorCanadianEngland6522 Nov 2021Active

Shareholders

Shareholders (1)

Sania Therapeutics, Inc.
100.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Sania Therapeutics Inc.

Ceased 22 Nov 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026OfficersTermination of Joseph Korff as director on 10 Apr 2026
1 Apr 2026OfficersAppointment of Dr Simon Kerry as director on 19 Mar 2026
15 Jan 2026AccountsAnnual accounts made up to 31 Mar 2025
4 Dec 2025Confirmation StatementConfirmation statement made on 21 Nov 2025 with no updates
2 Dec 2025OfficersChange to director Professor Robert Morris Brownstone on 2 Feb 2024
10 Apr 2026 Officers

Termination of Joseph Korff as director on 10 Apr 2026

1 Apr 2026 Officers

Appointment of Dr Simon Kerry as director on 19 Mar 2026

15 Jan 2026 Accounts

Annual accounts made up to 31 Mar 2025

4 Dec 2025 Confirmation Statement

Confirmation statement made on 21 Nov 2025 with no updates

2 Dec 2025 Officers

Change to director Professor Robert Morris Brownstone on 2 Feb 2024

Recent Activity

Latest Activity

Termination of Joseph Korff as director on 10 Apr 2026

2 months ago on 10 Apr 2026

Appointment of Dr Simon Kerry as director on 19 Mar 2026

2 months ago on 1 Apr 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 15 Jan 2026

Confirmation statement made on 21 Nov 2025 with no updates

6 months ago on 4 Dec 2025

Change to director Professor Robert Morris Brownstone on 2 Feb 2024

6 months ago on 2 Dec 2025